Guido Eibl
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
- Pharmacology 13
- Flavonoids in Medical Research 6
- Inflammatory mediators and NSAID effects 4
- Berberine and alkaloids research 2
-
- Cancer, Lipids, and Metabolism 4
- Co-authors
- O. Joe HinesHoward A. ReberAnna S. GukovskayaEliane AngstVay Liang W. GoAune MoroDavid W. DawsonXuyang Lu
- Journals
- Pancreas (8 papers)Gastroenterology (6 papers)Surgery (3 papers)Journal of Surgical Research (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Guido Eibl
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 396
- Oncology 531
- Pharmacology 242
- Biochemistry 64
- Molecular Biology 723
Countries citing papers authored by Guido Eibl
This map shows the geographic impact of Guido Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Eibl more than expected).
Fields of papers citing papers by Guido Eibl
This network shows the impact of papers produced by Guido Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Eibl. The network helps show where Guido Eibl may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Eibl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 13 | |
| 2 | 2018 | 14 | |
| 3 | 2015 | 11 | |
| 4 | 2013 | 205 | |
| 5 | 2013 | 43 | |
| 6 | 2012 | 108 | |
| 7 | 2012 | 93 | |
| 8 | 2012 | 2 | |
| 9 | 2012 | 1 | |
| 10 | 2011 | 79 | |
| 11 | 2011 | 153 | |
| 12 | 2011 | 56 | |
| 13 | 2011 | 38 | |
| 14 | 2010 | 24 | |
| 15 | 2010 | 26 | |
| 16 | 2009 | 1 | |
| 17 | 2008 | 51 | |
| 18 | 2008 | 70 | |
| 19 | 2008 | 37 | |
| 20 | 2005 | 79 |
About Guido Eibl
Guido Eibl is a scholar working on Pharmacology, Cancer Research, Oncology, Toxicology and Molecular Biology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Flavonoids in Medical Research (6 papers), Cancer Mechanisms and Therapy (4 papers), Cancer, Lipids, and Metabolism (4 papers), Natural product bioactivities and synthesis (4 papers), Inflammatory mediators and NSAID effects (4 papers), Berberine and alkaloids research (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (396 citations), Oncology (531 citations), Pharmacology (242 citations), Biochemistry (64 citations) and Molecular Biology (723 citations). Guido Eibl has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include O. Joe Hines, Howard A. Reber, Anna S. Gukovskaya, Eliane Angst, Vay Liang W. Go, Aune Moro, David W. Dawson, Xuyang Lu, Kathleen M. Hertzer and Graham Donald. Their work appears in journals such as Pancreas, Gastroenterology, Surgery, Journal of Surgical Research and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.